What You Should Know:
- Apstar Pharma acquires the assets of respiratory health company Cohero Health to expands its digital portfolio with a focus on respiratory disease management.
- Cohero Health develops digital tools and technologies to improve respiratory care, reduce avoidable costs, and optimize medication utilization.
AptarGroup, Inc., a global leader in consumer dispensing, active packaging, drug delivery solutions, and services, announces that it has acquired all operating
Read More
respiratory disease management platform
Propeller Health Unveils API to Provide Local Asthma Conditions Nationwide
Propeller Health, a digital health company developing solutions respiratory medicine has released the first ever API to provide local asthma conditions to anyone across the United States. The new service, Air by Propeller, is open and free to use that enables other individuals and organizations to use its local asthma condition calculations to improve the health of people with chronic respiratory disease.Propeller has trained a machine learning model based on millions of days of anonymized data
Read More
ResApp Licenses New Algorithm to Improve Diagnostic Screening for Childhood Pneumonia
ResApp Health Limited, a digital health startup provider of smartphone apps for respiratory disease diagnosis and management has signed a licensing agreement with UniQuest, the main commercialization company of The University of Queensland. The licensing agreement includes an additional diagnostic toolset of machine-learning algorithms that use a combination of clinical features to screen for childhood pneumonia. Pneumonia is the leading cause of mortality for children below five years of age.
Read More
Cohero Health Adds Strategic Investors Samsung NEXT, Omron Health to Support Commercialization of BreatheSmart
Cohero Health, a NYC-based digital health company developing connected health tools and technologies to empower respiratory patients and improve care through smart mobile devices, has added strategic investors Samsung NEXT and Omron Healthcare to its oversubscribed Series A round. The company originally announced its $9M Series A in late 2016 but elected to allow forthe investment of additional strategic capital. With the addition of the two new strategic investors/partners, the Series A round
Read More
